---
document_datetime: 2024-08-30 11:18:36
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/piasky-epar-all-authorised-presenations_en.pdf
document_name: piasky-epar-all-authorised-presenations_en.pdf
version: success
processing_time: 0.68966
conversion_datetime: 2025-12-14 16:17:40.386433
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form             | Route of Administration           | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|---------------------------------|-----------------------------------|-----------------------|---------------------------|-------------|
| EU/1/24/1848/001 | Piasky            | 340 mg     | Solution for injection/infusion | Intravenous use, Subcutaneous use | vial (glass)          | 2 ml (170 mg/ml)          | 1 vial      |